INS and obesity due to melanocortin 4 receptor deficiency: Among the benefits are the improvement of glucose-stimulated insulin secretion, the decrease in IR, fasting glucose levels and body fat, and the increase in fat-free mass, which may consequently help reduce obesity, T2D, and IR32.